Myths about Branded-Generic Medicines
The medication of Branded-Generic
drugs is created to be same as of already existing and marketed patent
drugs be it in dosage form, safety,
strength, route of administration, quality, performance
characteristics, effectiveness and intended use of the drug.
Branded-Generic drug makers certainly bring competition to the drug
market because of their low-priced drugs. But still, some patients
prefer using patented ones instead of Branded-Generic ones. Let’s look
at the myths our population has in their minds regarding Branded-Generic medicines.
Myth 1: Many of you must have had this question quite a few times in your mind despite Branded-Generic drugs being cheaper assure you same quality and effectiveness as of patent drug how?
The fact behind this is
Branded-Generic drugs are cheaper as compared to patent drugs because in
that case, the manufacturers did not have to spend on the expenses of
developing and marketing a new drug. Whenever a company introduces a new
drug into the market, the company has already spent a substantial
amount of money on research, development, marketing and promotion of the
drug. All that the Branded-Generic drug manufacturers have to do is a
basic level of marketing of the new Branded-Generic drug. A patent is
henceforth granted to the firm that developed that very particular drug
which further gives the company an exclusive right to sell the drug as
long as the patent is in effect.
Myth 2: Branded-Generic drugs compromise on quality standards in the production phase.
It’s not true. The fact is the
production of all Branded-Generic drugs follow the same quality
standards for making, testing and packaging of drugs as the patented
manufacturers do. In fact, sometimes, many Branded-Generic drugs are
produced in the exact same factory where the patent drugs were produced
following the same measures and standards as the patented drugs had gone
through.
Myth 3: Branded-Generic Drug makers sell their products at slashed prices.
The reason why Branded-Generic drug
makers can sell their product at lower prices is that their drugs do not
compromise in terms of quality with patent drugs. Branded-Generic drug
sellers sell at a lower price because they do not have to recover
anything like their initial investment in research and development,
clinical trials nor do they have to spend millions on tv commercials and
marketing campaigns as the patented drug producers typically do. All
they have done is spent an amount on the basic level of marketing of the
newly launched drug. The Branded-Generic drug manufacturers can thus
pass these cost savings on to their patients.
Myth 4: Branded-Generic drugs are not as effective as patent drugs.
It’s not true. Branded-Generic drugs
have to prove bioequivalency with the patent drug showing that the drug
works in the same manner in the human body as a patent drug does.
Sometimes, Branded-Generic versions of the drug have different colors,
flavors, or combinations of inactive ingredients than the original
medications but don’t need to worry they have the same medicinal effects
as patented ones.More
As the expense of healthcare services
keeps on taking off over the rate of inflation, Branded-Generics are an
uncommon source of healthcare savings. As the above rundown shows,
there’s no distinction in the adequacy or quality manufacturing
standards among Branded-Generics and patented drugs. Surely, they are
both frequently created in precisely the same generation plant under the
very same conditions. While you may not feel any distinction in your
body, you can unquestionably feel it in your pocket.
Comments
Post a Comment